INS and type 2 diabetes mellitus: After ajustment for clustering on city, those who were covered by commercial insurance (P < 0.001, vs. none of insurance) and received insulin therapy (P < 0.001, vs. without insulin therapy) were significantly associated with a higher annual DMC of T2DM, with 28% and 58% increase respectively.